$ONC
BeiGene, Ltd.

2020 Q2 Form 10-Q Financial Statement

#000165130820000117 Filed on August 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $65.64M $243.3M
YoY Change -73.03% 360.85%
Cost Of Revenue $14.31M $17.84M
YoY Change -19.8% 185.15%
Gross Profit $51.33M $225.5M
YoY Change -77.24% 384.46%
Gross Profit Margin 78.2% 92.67%
Selling, General & Admin $124.0M $82.25M
YoY Change 50.82% 82.13%
% of Gross Profit 241.68% 36.47%
Research & Development $286.0M $228.8M
YoY Change 25.01% 39.27%
% of Gross Profit 557.14% 101.44%
Depreciation & Amortization $7.679M $3.363M
YoY Change 128.34% 60.22%
% of Gross Profit 14.96% 1.49%
Operating Expenses $410.0M $311.0M
YoY Change 31.83% 48.52%
Operating Profit -$358.9M -$85.83M
YoY Change 318.11% -47.36%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $19.98M -$878.0K
YoY Change -2375.17% -1270.67%
Pretax Income -$337.8M -$83.83M
YoY Change 302.97% -47.96%
Income Tax -$1.475M $2.129M
% Of Pretax Income
Net Earnings -$335.2M -$85.57M
YoY Change 291.73% -45.46%
Net Earnings / Revenue -510.71% -35.16%
Basic Earnings Per Share -$0.33
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 1.010B shares 777.7M shares
Diluted Shares Outstanding 1.010B shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.153B
YoY Change
Cash & Equivalents $1.345B $918.9M
Short-Term Investments $1.808B
Other Short-Term Assets
YoY Change
Inventory $33.23M $49.05M
Prepaid Expenses
Receivables $61.66M $58.11M
Other Receivables
Total Short-Term Assets $3.392B $1.756B
YoY Change 93.22%
LONG-TERM ASSETS
Property, Plant & Equipment $258.1M $212.7M
YoY Change 21.36%
Goodwill $109.0K $109.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $26.24M
YoY Change
Other Assets $112.4M $60.16M
YoY Change 86.81%
Total Long-Term Assets $510.9M $394.6M
YoY Change 29.46%
TOTAL ASSETS
Total Short-Term Assets $3.392B $1.756B
Total Long-Term Assets $510.9M $394.6M
Total Assets $3.903B $2.150B
YoY Change 81.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $157.2M $148.5M
YoY Change 5.81%
Accrued Expenses $207.9M
YoY Change
Deferred Revenue $0.00
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $26.06M $8.740M
YoY Change 198.18%
Total Short-Term Liabilities $551.2M $271.7M
YoY Change 102.88%
LONG-TERM LIABILITIES
Long-Term Debt $131.5M $84.49M
YoY Change 55.63%
Other Long-Term Liabilities $46.51M $38.10M
YoY Change 22.08%
Total Long-Term Liabilities $805.6M $307.4M
YoY Change 162.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $551.2M $271.7M
Total Long-Term Liabilities $805.6M $307.4M
Total Liabilities $1.357B $579.1M
YoY Change 134.31%
SHAREHOLDERS EQUITY
Retained Earnings -$2.655B -$1.260B
YoY Change 110.63%
Common Stock $102.0K $78.00K
YoY Change 30.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.536B $1.554B
YoY Change
Total Liabilities & Shareholders Equity $3.903B $2.150B
YoY Change 81.52%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$335.2M -$85.57M
YoY Change 291.73% -45.46%
Depreciation, Depletion And Amortization $7.679M $3.363M
YoY Change 128.34% 60.22%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001651308
dei Entity File Number
EntityFileNumber
001-37686
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1176415671 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
BEIGENE, LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1209416
dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Mourant Governance Services (Cayman) Limited
dei Entity Address Address Line2
EntityAddressAddressLine2
94 Solaris Avenue, Camana Bay
dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
dei Entity Address Country
EntityAddressCountry
KY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1108
dei City Area Code
CityAreaCode
345
dei Local Phone Number
LocalPhoneNumber
949-4123
dei Security12b Title
Security12bTitle
American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
BGNE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1176415671 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1345014000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
618011000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
283000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
288000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1807744000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
364728000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61663000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70878000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
33234000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
28553000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
144466000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
90238000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
3392404000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1172696000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4602000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2476000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
258106000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
242402000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
90620000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
82520000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5375000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5846000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
39801000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
37894000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
112382000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68455000 USD
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
510886000 USD
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
439593000 USD
CY2020Q2 us-gaap Assets
Assets
3903290000 USD
CY2019Q4 us-gaap Assets
Assets
1612289000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
157173000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
122488000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
207921000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
163556000 USD
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
10448000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
13454000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12888000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10814000 USD
CY2020Q2 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
136704000 USD
CY2019Q4 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
0 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
26061000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
551195000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
310312000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
131491000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
83311000 USD
CY2020Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
160164000 USD
CY2019Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
157384000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31165000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25833000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11379000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10532000 USD
CY2020Q2 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
424890000 USD
CY2019Q4 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
0 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46514000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46562000 USD
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
805603000 USD
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
323622000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
1356798000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
633934000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1014976692 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1014976692 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
801340698 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
801340698 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
102000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
79000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5200275000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2925970000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9299000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8001000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2654780000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1955843000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2536298000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
962205000 USD
CY2020Q2 us-gaap Minority Interest
MinorityInterest
10194000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
16150000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2546492000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
978355000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3903290000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1612289000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65635000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243346000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117694000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
321179000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14307000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17839000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28456000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33100000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
285968000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
228760000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
590270000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
407111000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124049000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
82248000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
231130000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
139893000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
188000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
332000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
471000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
663000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
424512000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
329179000 USD
us-gaap Costs And Expenses
CostsAndExpenses
850327000 USD
us-gaap Costs And Expenses
CostsAndExpenses
580767000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-358877000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-85833000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-732633000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-259588000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1108000 USD
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2886000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7798000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7363000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19976000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-878000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23657000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
850000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-337793000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-83825000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-701178000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-251375000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1475000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2129000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2648000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-336318000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-85954000 USD
us-gaap Profit Loss
ProfitLoss
-701257000 USD
us-gaap Profit Loss
ProfitLoss
-254023000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1116000 USD
CY2019Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-384000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2320000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-813000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-335202000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-85570000 USD
us-gaap Net Income Loss
NetIncomeLoss
-698937000 USD
us-gaap Net Income Loss
NetIncomeLoss
-253210000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1010230470 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
777509102 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1007967904 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
776137299 shares
CY2020Q2 bgne Earnings Per American Depository Share
EarningsPerAmericanDepositoryShare
-4.31
CY2019Q2 bgne Earnings Per American Depository Share
EarningsPerAmericanDepositoryShare
-1.43
bgne Earnings Per American Depository Share
EarningsPerAmericanDepositoryShare
-9.01
bgne Earnings Per American Depository Share
EarningsPerAmericanDepositoryShare
-4.24
CY2020Q2 bgne Weighted Average Number Of American Depository Shares Outstanding
WeightedAverageNumberOfAmericanDepositorySharesOutstanding
77710036 shares
CY2019Q2 bgne Weighted Average Number Of American Depository Shares Outstanding
WeightedAverageNumberOfAmericanDepositorySharesOutstanding
59808392 shares
bgne Weighted Average Number Of American Depository Shares Outstanding
WeightedAverageNumberOfAmericanDepositorySharesOutstanding
77535993 shares
bgne Weighted Average Number Of American Depository Shares Outstanding
WeightedAverageNumberOfAmericanDepositorySharesOutstanding
59702869 shares
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-336318000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-85954000 USD
us-gaap Profit Loss
ProfitLoss
-701257000 USD
us-gaap Profit Loss
ProfitLoss
-254023000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1732000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7337000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2617000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3582000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4470000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
901000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1228000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1586000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-339056000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-92390000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-702646000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-256019000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1103000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-523000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2411000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1058000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-337953000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-91867000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-700235000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-254961000 USD
us-gaap Profit Loss
ProfitLoss
-701257000 USD
us-gaap Profit Loss
ProfitLoss
-254023000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15617000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7111000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
83723000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
58994000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
11264000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
11307000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
bgne Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
43000000 USD
bgne Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
49000000 USD
bgne Amortizationof Research And Development Financing Liability
AmortizationofResearchAndDevelopmentFinancingLiability
-55240000 USD
bgne Amortizationof Research And Development Financing Liability
AmortizationofResearchAndDevelopmentFinancingLiability
0 USD
bgne Interest Expense Operating Activities
InterestExpenseOperatingActivities
5106000 USD
bgne Interest Expense Operating Activities
InterestExpenseOperatingActivities
3759000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1060000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1456000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-863000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-5458000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9094000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17052000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4681000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32806000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
54590000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5923000 USD
bgne Increase Decrease In Operating Lease Rightof Use Asset
IncreaseDecreaseInOperatingLeaseRightofUseAsset
7465000 USD
bgne Increase Decrease In Operating Lease Rightof Use Asset
IncreaseDecreaseInOperatingLeaseRightofUseAsset
3604000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2628000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
10293000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
34851000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21431000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
44471000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
3535000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3006000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3713000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-27982000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
7406000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
383000 USD
bgne Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-49000 USD
bgne Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
21000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-604886000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-218076000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54138000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43275000 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
2025000 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
0 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2442943000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
710791000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
997242000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
49525000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1167491000 USD
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
43000000 USD
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
49000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1544864000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
364425000 USD
bgne Proceeds From Issuance Of Common Stock Net Of Underwriter Discount
ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount
2162407000 USD
bgne Proceeds From Issuance Of Common Stock Net Of Underwriter Discount
ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount
0 USD
bgne Proceeds From Research And Development Financing Liability
ProceedsFromResearchAndDevelopmentFinancingLiability
616834000 USD
bgne Proceeds From Research And Development Financing Liability
ProceedsFromResearchAndDevelopmentFinancingLiability
0 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
43704000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
26197000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
28198000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10642000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2883161000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58346000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4287000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2732000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
729124000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
201963000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
620775000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
740713000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1349899000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
942676000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1345014000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
918948000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
283000 USD
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
14567000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4602000 USD
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9161000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9250000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7874000 USD
us-gaap Interest Paid Net
InterestPaidNet
3354000 USD
us-gaap Interest Paid Net
InterestPaidNet
2090000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
28962000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
35927000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
978355000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2162407000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11629000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
38255000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1349000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-364939000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2827056000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16569000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
45468000 USD
CY2020Q2 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
3545000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2738000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-336318000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2546492000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1753647000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6269000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
26392000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4440000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-168069000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1622679000 USD
CY2019Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
4000000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4373000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
32602000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6436000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-85954000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1571264000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of estimates</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and the standalone selling price of each performance obligation in the Company’s revenue arrangements, estimating the fair value of net assets acquired in business combinations, assessing the impairment of long-lived assets, share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates.</span></div>
CY2020Q2 bgne Upfront Payments For Collaboration
UpfrontPaymentsForCollaboration
0 USD
CY2019Q2 bgne Upfront Payments For Collaboration
UpfrontPaymentsForCollaboration
20000000 USD
bgne Upfront Payments For Collaboration
UpfrontPaymentsForCollaboration
43000000 USD
bgne Upfront Payments For Collaboration
UpfrontPaymentsForCollaboration
30000000 USD
CY2020Q2 bgne Milestone Payments
MilestonePayments
0 USD
CY2019Q2 bgne Milestone Payments
MilestonePayments
0 USD
bgne Milestone Payments
MilestonePayments
5000000 USD
bgne Milestone Payments
MilestonePayments
0 USD
CY2020Q2 bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
0 USD
CY2019Q2 bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
20000000 USD
bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
48000000 USD
bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
30000000 USD
CY2020Q1 bgne Upfront Payments For Collaboration
UpfrontPaymentsForCollaboration
40000000 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
4885000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1805274000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2470000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1807744000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
363440000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1288000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
364728000 USD
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
3762000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
0 USD
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
118000 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 USD
CY2019Q2 us-gaap Depreciation
Depreciation
3363000 USD
us-gaap Depreciation
Depreciation
6448000 USD
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
29354000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28553000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
33234000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
28553000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
264735000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
258156000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51157000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36709000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
258106000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
242402000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
7679000 USD
us-gaap Depreciation
Depreciation
15146000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8316000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2941000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5375000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8316000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2470000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5846000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
188000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
471000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
332000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
663000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
375000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
750000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
750000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
750000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
750000 USD
CY2020Q2 bgne Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
2000000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1475000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2129000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2648000 USD
CY2020Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
5586000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5783000 USD
CY2020Q2 bgne Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives
UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives
780000 USD
bgne Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives
UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives
1150000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
121000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
121000 USD
CY2020Q2 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
79458000 USD
CY2019Q4 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
65886000 USD
CY2020Q2 us-gaap Prepaid Taxes
PrepaidTaxes
18792000 USD
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
9498000 USD
CY2020Q2 bgne Payroll Tax Receivable Current
PayrollTaxReceivableCurrent
17391000 USD
CY2019Q4 bgne Payroll Tax Receivable Current
PayrollTaxReceivableCurrent
5365000 USD
CY2020Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
3636000 USD
CY2019Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1932000 USD
CY2020Q2 us-gaap Prepaid Insurance
PrepaidInsurance
6231000 USD
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
711000 USD
CY2020Q2 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
10025000 USD
CY2019Q4 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
3829000 USD
CY2020Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
8933000 USD
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3017000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
144466000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
90238000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
109000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
109000 USD
CY2020Q2 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
30449000 USD
CY2019Q4 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
10289000 USD
CY2020Q2 bgne Prepaid Construction Cost
PrepaidConstructionCost
26267000 USD
CY2019Q4 bgne Prepaid Construction Cost
PrepaidConstructionCost
24881000 USD
CY2020Q2 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
25705000 USD
CY2019Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
29967000 USD
CY2020Q2 bgne Rental Deposits And Other
RentalDepositsAndOther
3611000 USD
CY2019Q4 bgne Rental Deposits And Other
RentalDepositsAndOther
3209000 USD
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
26241000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
112382000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68455000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48980000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54156000 USD
CY2020Q2 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
99390000 USD
CY2019Q4 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
62794000 USD
CY2020Q2 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
31549000 USD
CY2019Q4 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
25645000 USD
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
22564000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9648000 USD
CY2020Q2 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
3896000 USD
CY2019Q4 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
3198000 USD
CY2020Q2 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
1542000 USD
CY2019Q4 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
8115000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
207921000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
163556000 USD
CY2020Q2 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
46340000 USD
CY2019Q4 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
46391000 USD
CY2020Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
174000 USD
CY2019Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
171000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46514000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46562000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-335202000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-85570000 USD
us-gaap Net Income Loss
NetIncomeLoss
-698937000 USD
us-gaap Net Income Loss
NetIncomeLoss
-253210000 USD
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1010230470 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
777509102 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1007967904 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
776137299 shares
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45468000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32602000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
83723000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
58994000 USD
CY2020Q2 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
CY2020Q2 bgne Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital
RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital
0.50
CY2020Q2 bgne Restricted Net Assets Appropriated To Statutory Reserves
RestrictedNetAssetsAppropriatedToStatutoryReserves
0 USD
CY2019Q2 bgne Restricted Net Assets Appropriated To Statutory Reserves
RestrictedNetAssetsAppropriatedToStatutoryReserves
0 USD
CY2020Q2 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
CY2020Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
126864000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65635000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243346000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117694000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
321179000 USD

Files In Submission

Name View Source Status
0001651308-20-000117-index-headers.html Edgar Link pending
0001651308-20-000117-index.html Edgar Link pending
0001651308-20-000117.txt Edgar Link pending
0001651308-20-000117-xbrl.zip Edgar Link pending
bgne-20200630.htm Edgar Link pending
bgne-20200630.xsd Edgar Link pending
bgne-20200630_cal.xml Edgar Link unprocessable
bgne-20200630_def.xml Edgar Link unprocessable
bgne-20200630_htm.xml Edgar Link completed
bgne-20200630_lab.xml Edgar Link unprocessable
bgne-20200630_pre.xml Edgar Link unprocessable
exhibit102-formofrsuaw.htm Edgar Link pending
exhibit103-formofrsuaw.htm Edgar Link pending
exhibit104-formofnonxq.htm Edgar Link pending
exhibit105-formofnonxq.htm Edgar Link pending
exhibit106-formofnonxq.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending